193 related articles for article (PubMed ID: 30545372)
1. The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism.
Feng Y; Wu M; Li S; He X; Tang J; Peng W; Zeng B; Deng C; Ren G; Xiang T
J Exp Clin Cancer Res; 2018 Dec; 37(1):313. PubMed ID: 30545372
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis.
Le X; Mu J; Peng W; Tang J; Xiang Q; Tian S; Feng Y; He S; Qiu Z; Ren G; Huang A; Lin Y; Tao Q; Xiang T
Theranostics; 2020; 10(21):9495-9511. PubMed ID: 32863941
[TBL] [Abstract][Full Text] [Related]
3. Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death.
Rowland LK; Campbell PS; Mavingire N; Wooten JV; McLean L; Zylstra D; Thorne G; Daly D; Boyle K; Whang S; Unternaehrer J; Brantley EJ
J Cell Biochem; 2019 Apr; 120(4):6004-6014. PubMed ID: 30450577
[TBL] [Abstract][Full Text] [Related]
4. Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells.
Gorr TA; Wichmann D; Pilarsky C; Theurillat JP; Fabrizius A; Laufs T; Bauer T; Koslowski M; Horn S; Burmester T; Hankeln T; Kristiansen G
Acta Physiol (Oxf); 2011 Jul; 202(3):563-81. PubMed ID: 20958924
[TBL] [Abstract][Full Text] [Related]
5. Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.
Shivapurkar N; Stastny V; Okumura N; Girard L; Xie Y; Prinsen C; Thunnissen FB; Wistuba II; Czerniak B; Frenkel E; Roth JA; Liloglou T; Xinarianos G; Field JK; Minna JD; Gazdar AF
Cancer Res; 2008 Sep; 68(18):7448-56. PubMed ID: 18794132
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain-derived neurotrophic factor.
Gao B; Hao S; Tian W; Jiang Y; Zhang S; Guo L; Zhao J; Zhang G; Yan J; Luo D
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 27813254
[TBL] [Abstract][Full Text] [Related]
7. Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines.
Oleksiewicz U; Liloglou T; Tasopoulou KM; Daskoulidou N; Bryan J; Gosney JR; Field JK; Xinarianos G
Hum Mol Genet; 2013 Aug; 22(16):3207-17. PubMed ID: 23591990
[TBL] [Abstract][Full Text] [Related]
8. Cytoglobin promotes sensitivity to ferroptosis by regulating p53-YAP1 axis in colon cancer cells.
Ye S; Xu M; Zhu T; Chen J; Shi S; Jiang H; Zheng Q; Liao Q; Ding X; Xi Y
J Cell Mol Med; 2021 Apr; 25(7):3300-3311. PubMed ID: 33611811
[TBL] [Abstract][Full Text] [Related]
9. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.
Qu X; Zhao B; Hu M; Ji Z; Xu J; Xia W; Qu Y
Med Sci Monit; 2018 Jun; 24():3987-3996. PubMed ID: 29893377
[TBL] [Abstract][Full Text] [Related]
11. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
[TBL] [Abstract][Full Text] [Related]
12. ΔNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer.
Latina A; Viticchiè G; Lena AM; Piro MC; Annicchiarico-Petruzzelli M; Melino G; Candi E
Oncogene; 2016 Mar; 35(12):1493-503. PubMed ID: 26096935
[TBL] [Abstract][Full Text] [Related]
13. The Antioxidative Role of Cytoglobin in Podocytes: Implications for a Role in Chronic Kidney Disease.
Randi EB; Vervaet B; Tsachaki M; Porto E; Vermeylen S; Lindenmeyer MT; Thuy LTT; Cohen CD; Devuyst O; Kistler AD; Szabo C; Kawada N; Hankeln T; Odermatt A; Dewilde S; Wenger RH; Hoogewijs D
Antioxid Redox Signal; 2020 Jun; 32(16):1155-1171. PubMed ID: 31910047
[No Abstract] [Full Text] [Related]
14. Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.
Yin X; Xiang T; Mu J; Mao H; Li L; Huang X; Li C; Feng Y; Luo X; Wei Y; Peng W; Ren G; Tao Q
Oncotarget; 2016 Aug; 7(32):51720-51732. PubMed ID: 27351130
[TBL] [Abstract][Full Text] [Related]
15. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
16. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
17. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
18. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
[TBL] [Abstract][Full Text] [Related]
19. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
20. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
Tan XL; Guo L; Wang GH
Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
